We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and Eu... MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union. Show more
LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria...
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company...
- Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for Grade 2/3 radiation-induced xerostomia to be considered pivotal supporting potential BLA filing - Company...
LONDON and NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.5 | 10.2459016393 | 4.88 | 5.39 | 4.77 | 114607 | 4.98280954 | CS |
4 | -0.2 | -3.58422939068 | 5.58 | 5.9 | 4.68 | 135774 | 5.1695362 | CS |
12 | -1.27 | -19.0977443609 | 6.65 | 6.85 | 4.68 | 148137 | 5.77953977 | CS |
26 | 0.29 | 5.6974459725 | 5.09 | 7.6 | 4.32 | 205016 | 5.86359884 | CS |
52 | -0.76 | -12.3778501629 | 6.14 | 8.35 | 3.49 | 215088 | 5.60860079 | CS |
156 | -8.29 | -60.6437454279 | 13.67 | 24.8948 | 3.49 | 183794 | 9.92649065 | CS |
260 | -12.76 | -70.341786108 | 18.14 | 30.23 | 3.49 | 166837 | 12.38062998 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions